A panel of health experts convened this week to decide which vaccine the U.S. should use against COVID-19 this fall.The federal advisory group decided on Wednesday the new vaccine should focus on the JN.1 lineage that has dominated virus strains in recommendations.The Vaccines and Related Biological Products Advisory Committee – composed of leading U.S. health…
